Deberdt et al.[12]; (2005) |
Double blind placebo controlled |
16 |
Amantadine 100-300 mg Placebo |
40±12 41±12 |
Olanzapine |
–0.19+1.28 |
Graham et al.[13]; (2005) |
Double blind placebo controlled |
12 |
Amantadine 300 mg/day Placebo |
Adult |
Olanzapine |
–0.36+3.95 |
Baptista et al.[14]; (2007) |
Double blind placebo controlled |
12 |
Metformin 850-2550 mg/day Placebo |
44.3 44.6 |
Olanzapine |
–1.4 0.18 |
Baptista et al.[15]; (2008) |
Double blind placebo controlled |
12 |
Metformin 850-2550 mg/day + sibutramine Placebo |
45.5 49.3 |
Olanzapine |
–2.8 –1.4 |
Klein et al.[16]; (2006) |
Double blind placebo controlled |
16 |
Metformin 250-850 mg/day Placebo |
12.9 13.3 |
Olanzapine, Risperidone |
–0.13+4.01 |
Atmaca et al.[17]; (2003) |
Double blind placebo controlled |
8 |
Nizatidine 150 mg bd Placebo |
27.1 28.7 |
Olanzapine |
–4.5+2.3 |
Chengappa et al.[18]; (2007) |
Double blind placebo controlled |
8 |
Topiramate 300 mg/day placebo |
42.6 42.8 |
Valproate |
–1.49+2.72 |
Our study |
Open-labeled randomized controlled |
8 |
Acetazolamide |
37.76 45.29 |
Risperidone and Olanzapine |
–0.57+2.62 |